Cargando…
Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells
PURPOSE: Titanium dioxide nanoparticles, 25 nm in size of crystallites (TiO(2) P25), are among the most produced nanomaterials worldwide. The broad use of TiO(2) P25 in material science has implied a request to evaluate their biological effects, especially in the lungs. Hence, the pulmonary A549 cel...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482439/ https://www.ncbi.nlm.nih.gov/pubmed/36124012 http://dx.doi.org/10.2147/IJN.S374955 |
_version_ | 1784791455403868160 |
---|---|
author | Bacova, Jana Knotek, Petr Kopecka, Katerina Hromadko, Ludek Capek, Jan Nyvltova, Pavlina Bruckova, Lenka Schröterova, Ladislava Sestakova, Blanka Palarcik, Jiri Motola, Martin Cizkova, Dana Bezrouk, Ales Handl, Jiri Fiala, Zdenek Rudolf, Emil Bilkova, Zuzana Macak, Jan M Rousar, Tomas |
author_facet | Bacova, Jana Knotek, Petr Kopecka, Katerina Hromadko, Ludek Capek, Jan Nyvltova, Pavlina Bruckova, Lenka Schröterova, Ladislava Sestakova, Blanka Palarcik, Jiri Motola, Martin Cizkova, Dana Bezrouk, Ales Handl, Jiri Fiala, Zdenek Rudolf, Emil Bilkova, Zuzana Macak, Jan M Rousar, Tomas |
author_sort | Bacova, Jana |
collection | PubMed |
description | PURPOSE: Titanium dioxide nanoparticles, 25 nm in size of crystallites (TiO(2) P25), are among the most produced nanomaterials worldwide. The broad use of TiO(2) P25 in material science has implied a request to evaluate their biological effects, especially in the lungs. Hence, the pulmonary A549 cell line has been used to estimate the effects of TiO(2) P25. However, the reports have provided dissimilar results on caused toxicity. Surprisingly, the physicochemical factors influencing TiO(2) P25 action in biological models have not been evaluated in most reports. Thus, the objective of the present study is to characterize the preparation of TiO(2) P25 for biological testing in A549 cells and to evaluate their biological effects. METHODS: We determined the size and crystallinity of TiO(2) P25. We used four techniques for TiO(2) P25 dispersion. We estimated the colloid stability of TiO(2) P25 in distilled water, isotonic NaCl solution, and cell culture medium. We applied the optimal dispersion conditions for testing the biological effects of TiO(2) P25 (0–100 µg.mL(−1)) in A549 cells using biochemical assays (dehydrogenase activity, glutathione levels) and microscopy. RESULTS: We found that the use of fetal bovine serum in culture medium is essential to maintain sufficient colloid stability of dispersed TiO(2) P25. Under these conditions, TiO(2) P25 were unable to induce a significant impairment of A549 cells according to the results of biochemical and microscopy evaluations. When the defined parameters for the use of TiO(2) P25 in A549 cells were met, similar results on the biological effects of TiO(2) P25 were obtained in two independent cell laboratories. CONCLUSION: We optimized the experimental conditions of TiO(2) P25 preparation for toxicity testing in A549 cells. The results presented here on TiO(2) P25-induced cellular effects are reproducible. Therefore, our results can be helpful for other researchers using TiO(2) P25 as a reference material. |
format | Online Article Text |
id | pubmed-9482439 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-94824392022-09-18 Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells Bacova, Jana Knotek, Petr Kopecka, Katerina Hromadko, Ludek Capek, Jan Nyvltova, Pavlina Bruckova, Lenka Schröterova, Ladislava Sestakova, Blanka Palarcik, Jiri Motola, Martin Cizkova, Dana Bezrouk, Ales Handl, Jiri Fiala, Zdenek Rudolf, Emil Bilkova, Zuzana Macak, Jan M Rousar, Tomas Int J Nanomedicine Original Research PURPOSE: Titanium dioxide nanoparticles, 25 nm in size of crystallites (TiO(2) P25), are among the most produced nanomaterials worldwide. The broad use of TiO(2) P25 in material science has implied a request to evaluate their biological effects, especially in the lungs. Hence, the pulmonary A549 cell line has been used to estimate the effects of TiO(2) P25. However, the reports have provided dissimilar results on caused toxicity. Surprisingly, the physicochemical factors influencing TiO(2) P25 action in biological models have not been evaluated in most reports. Thus, the objective of the present study is to characterize the preparation of TiO(2) P25 for biological testing in A549 cells and to evaluate their biological effects. METHODS: We determined the size and crystallinity of TiO(2) P25. We used four techniques for TiO(2) P25 dispersion. We estimated the colloid stability of TiO(2) P25 in distilled water, isotonic NaCl solution, and cell culture medium. We applied the optimal dispersion conditions for testing the biological effects of TiO(2) P25 (0–100 µg.mL(−1)) in A549 cells using biochemical assays (dehydrogenase activity, glutathione levels) and microscopy. RESULTS: We found that the use of fetal bovine serum in culture medium is essential to maintain sufficient colloid stability of dispersed TiO(2) P25. Under these conditions, TiO(2) P25 were unable to induce a significant impairment of A549 cells according to the results of biochemical and microscopy evaluations. When the defined parameters for the use of TiO(2) P25 in A549 cells were met, similar results on the biological effects of TiO(2) P25 were obtained in two independent cell laboratories. CONCLUSION: We optimized the experimental conditions of TiO(2) P25 preparation for toxicity testing in A549 cells. The results presented here on TiO(2) P25-induced cellular effects are reproducible. Therefore, our results can be helpful for other researchers using TiO(2) P25 as a reference material. Dove 2022-09-13 /pmc/articles/PMC9482439/ /pubmed/36124012 http://dx.doi.org/10.2147/IJN.S374955 Text en © 2022 Bacova et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Bacova, Jana Knotek, Petr Kopecka, Katerina Hromadko, Ludek Capek, Jan Nyvltova, Pavlina Bruckova, Lenka Schröterova, Ladislava Sestakova, Blanka Palarcik, Jiri Motola, Martin Cizkova, Dana Bezrouk, Ales Handl, Jiri Fiala, Zdenek Rudolf, Emil Bilkova, Zuzana Macak, Jan M Rousar, Tomas Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells |
title | Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells |
title_full | Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells |
title_fullStr | Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells |
title_full_unstemmed | Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells |
title_short | Evaluating the Use of TiO(2) Nanoparticles for Toxicity Testing in Pulmonary A549 Cells |
title_sort | evaluating the use of tio(2) nanoparticles for toxicity testing in pulmonary a549 cells |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482439/ https://www.ncbi.nlm.nih.gov/pubmed/36124012 http://dx.doi.org/10.2147/IJN.S374955 |
work_keys_str_mv | AT bacovajana evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT knotekpetr evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT kopeckakaterina evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT hromadkoludek evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT capekjan evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT nyvltovapavlina evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT bruckovalenka evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT schroterovaladislava evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT sestakovablanka evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT palarcikjiri evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT motolamartin evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT cizkovadana evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT bezroukales evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT handljiri evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT fialazdenek evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT rudolfemil evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT bilkovazuzana evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT macakjanm evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells AT rousartomas evaluatingtheuseoftio2nanoparticlesfortoxicitytestinginpulmonarya549cells |